small plans: nanotechnology for the building industry

Thursday, October 13, 2005

Biomaterials repair/replace human bone, tissues

Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH), a worldwide leader in the orthopaedics industry, announced today it has acquired worldwide exclusive distribution rights for genetically engineered xenogeneic tissues for regenerative therapies from Revivicor, Inc., which has an advanced transgenic technology platform for the production of tissues, cells and whole organs for human therapeutic applications. Zimmer initially plans to develop the technologies for orthopaedic applications, including the repair and replacement of damaged tendon, ligament, meniscus, cartilage, bone and spinal nucleus tissues. more . . .